Thomas J. Hudson

Thomas J. Hudson

Auto-generated profile, based on publicly available information

Thomas J. Hudson

Ontario Institute for Cancer Research, Toronto, Canada

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 February 2007 in Nature
Verified
Journal Article
Closed access
PDF file
RSRobert Sladek
Robert Sladek
GRGhislain Rocheleau
Ghislain Rocheleau
JRJohan Rung
Johan Rung
CDChristian Dina
Christian Dina
LSLishuang Shen
Lishuang Shen
PFPhilippe Froguel
Philippe Froguel

8 December 2005 in New England Journal of Medicine
Verified
Journal Article
Open access
PDF file
VLVivian G. Loo
Vivian G. Loo
LPLouise Poirier
Louise Poirier
MMMark A. Miller
Mark A. Miller
MOMatthew Oughton
Matthew Oughton
MLMichael D. Libman
Michael D. Libman
ADAndré Dascal
André Dascal
In March 2003, several hospitals in Quebec, Canada, noted a marked increase in the incidence of Clostridium difficile–associated diarrhea.

1 October 2001 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
JRJohn D. Rioux
John D. Rioux
MDMark J. Daly
Mark J. Daly
MSMark S. Silverberg
Mark S. Silverberg
KLKerstin Lindblad
Kerstin Lindblad
HSHillary Steinhart
Hillary Steinhart
THThomas J. Hudson
Thomas J. Hudson

3 December 2018 in Nature Genetics
Verified
Journal Article
Open access
JHJeroen R. Huyghe
Jeroen R. Huyghe
SBStephanie A. Bien
Stephanie A. Bien
THTabitha A. Harrison
Tabitha A. Harrison
HKHyun Min Kang
Hyun Min Kang
SCSai Chen
Sai Chen
UPUlrike Peters
Ulrike Peters
To further dissect the genetic architecture of colorectal cancer (CRC), we performed whole-genome sequencing of 1,439 cases and 720 controls, imputed discovered sequence variants and Haplotype Reference Consortium panel variants into genome-wide association study data, and tested for association in 34,869 cases and 29,051 controls. Findings were followed up in an additional 23,262 cases and 38,296 controls. We discovered a strongly protective 0.3% frequency variant signal at CHD1. In a combined meta-analysis of 125,478 individuals, we identified 40 new independent signals at P < 5 × 10-8, bringing the number of known independent signals for CRC to ~100. New signals implicate lower-frequency variants, Krüppel-like factors, Hedgehog signaling, Hippo-YAP signaling, long noncoding RNAs and somatic drivers, and support a role for immune function. Heritability analyses suggest that CRC risk is highly polygenic, and larger, more comprehensive studies enabling rare variant analysis will improve understanding of biology underlying this risk and influence personalized screening strategies and drug development.

23 October 1998 in Science
Verified
Journal Article
Closed access
PDF file
PDPanos Deloukas
Panos Deloukas
GSG. D. Schuler
G. D. Schuler
GGG. Gyapay
G. Gyapay
EBE. M. Beasley
E. M. Beasley
CSC. Soderlund
C. Soderlund
DBD. R. Bentley
D. R. Bentley
A map of 30,181 human gene–based markers was assembled and integrated with the current genetic map by radiation hybrid mapping. The new gene map contains nearly twice as many genes as the previous release, includes most genes that encode proteins of known function, and is twofold to threefold more accurate than the previous version. A redesigned, more informative and functional World Wide Web site ( www.ncbi.nlm.nih.gov/genemap ) provides the mapping information and associated data and annotations. This resource constitutes an important infrastructure and tool for the study of complex genetic traits, the positional cloning of disease genes, the cross-referencing of mammalian genomes, and validated human transcribed sequences for large-scale studies of gene expression.

5 December 2016 in Nature Genetics
Verified
Journal Article
Open access
TCthe BIOS Consortium
the BIOS Consortium
MBMarc Jan Bonder
Marc Jan Bonder
RLRené Luijk
René Luijk
DZDaria V Zhernakova
Daria V Zhernakova
MMMatthijs Moed
Matthijs Moed
BHBastiaan T Heijmans
Bastiaan T Heijmans
Peter 't Hoen, Lude Franke, Bastiaan Heijmans and colleagues present a combined analysis of methylome and transcriptome data from a large collection of whole-blood samples to infer the downstream effects of disease-associated variants. They identify a large number of trait-associated SNPs influencing methylation of CpG sites in trans, providing insights into the downstream functional effects of many disease-associated variants.